載入...
Crosstalk of TLR4, vascular NADPH oxidase, and COVID-19 in diabetes: What are the potential implications?
Toll-like receptor 4 (TLR4) contributes to the pathophysiology of diabetes. This happens, at least in part, because TLR4 modulates the enzyme NADPH oxidase, a primary source of ROS in vascular structures. Increased oxidative stress disrupts key vascular signaling mechanisms and drives the progressio...
Na minha lista:
| 發表在: | Vascul Pharmacol |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier Inc.
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8152239/ https://ncbi.nlm.nih.gov/pubmed/34051372 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vph.2021.106879 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|